Antimicrobial photodynamic therapy fighting polymicrobial infections - a journey from in vitro to in vivo
- PMID: 32996547
- DOI: 10.1039/d0pp00108b
Antimicrobial photodynamic therapy fighting polymicrobial infections - a journey from in vitro to in vivo
Abstract
Rapidly evolving multidrug resistance renders conventional antimicrobial strategies increasingly inefficient. This urges the exploration of alternative strategies with a lower potential of resistance development to control microbial infections. A promising option is antimicrobial photodynamic therapy (aPDT), especially in the setting of wound infections. In this study its effectiveness was tested as a treatment option for polymicrobially infected wounds in both in vitro and in vivo models. First, aPDT was applied to wound-relevant Gram-positive and Gram-negative bacteria in planktonic culture as the standard in vitro test system and compared different media to show a possible dependency of the therapy on the surrounding environment. In a second step, aPDT was investigated in an in vitro model mimicking the wound bed conditions using fibrin-coated culture plates. Finally, we tested aPDT in vivo in a polymicrobial infected wound healing model in immunocompromised BALB/c mice. In vitro, it was shown that the bactericidal effectiveness of aPDT was strongly dependent on the surrounding environment of the phototoxic reaction. In vivo, the significant delay in wound healing induced by polymicrobial infection was drastically diminished by a two-times application of aPDT using 100 μM methylene blue (generally regarded as safe for topical application on human skin) and 24 J cm-2 pulsed red LED light. Our experiments suggest that aPDT is capable of significantly improving wound healing also in complicated polymicrobially infected wound situations.
Similar articles
-
The role of the light source in antimicrobial photodynamic therapy.Chem Soc Rev. 2023 Mar 6;52(5):1697-1722. doi: 10.1039/d0cs01051k. Chem Soc Rev. 2023. PMID: 36779328 Review.
-
Synergistic gentamicin-photodynamic therapy against resistant bacteria in burn wound infections.Photodiagnosis Photodyn Ther. 2022 Sep;39:103034. doi: 10.1016/j.pdpdt.2022.103034. Epub 2022 Jul 23. Photodiagnosis Photodyn Ther. 2022. PMID: 35882288
-
Control of Burn Wound Infection by Methylene Blue-Mediated Photodynamic Treatment With Light-Emitting Diode Array Illumination in Rats.Lasers Surg Med. 2021 Nov;53(9):1238-1246. doi: 10.1002/lsm.23395. Epub 2021 Mar 3. Lasers Surg Med. 2021. PMID: 33655570
-
Antimicrobial photodynamic therapy - what we know and what we don't.Crit Rev Microbiol. 2018 Sep;44(5):571-589. doi: 10.1080/1040841X.2018.1467876. Epub 2018 May 11. Crit Rev Microbiol. 2018. PMID: 29749263 Review.
-
Antimicrobial photodynamic therapy on drug-resistant Pseudomonas aeruginosa-induced infection. An in vivo study.Photochem Photobiol. 2012 May-Jun;88(3):590-5. doi: 10.1111/j.1751-1097.2012.01137.x. Epub 2012 Mar 30. Photochem Photobiol. 2012. PMID: 22404212
Cited by
-
In vitro study: methylene blue-based antibacterial photodynamic inactivation of Pseudomonas aeruginosa.Appl Microbiol Biotechnol. 2024 Jan 23;108(1):169. doi: 10.1007/s00253-024-13009-5. Appl Microbiol Biotechnol. 2024. PMID: 38261091 Free PMC article.
-
Photophysical characterization of tetrahydroxyphenyl porphyrin Zn(II) and V(IV) complexes: experimental and DFT study.Biometals. 2023 Dec;36(6):1257-1272. doi: 10.1007/s10534-023-00514-9. Epub 2023 Jun 21. Biometals. 2023. PMID: 37344742
-
Antimicrobial activity of D-amino acid in combination with photo-sonoactivated hypericin nanoparticles against Acinetobacter baumannii.BMC Microbiol. 2023 Jan 19;23(1):23. doi: 10.1186/s12866-023-02758-4. BMC Microbiol. 2023. PMID: 36658487 Free PMC article.
-
Plasmonic Enhancement Strategies for Light-Driven Microbe Inactivation.J Phys Chem C Nanomater Interfaces. 2022 Feb 10;126(5):2325-2335. doi: 10.1021/acs.jpcc.1c09951. Epub 2022 Feb 1. J Phys Chem C Nanomater Interfaces. 2022. PMID: 36313122 Free PMC article.
-
Upconversion nanoparticles and its based photodynamic therapy for antibacterial applications: A state-of-the-art review.Front Chem. 2022 Oct 4;10:996264. doi: 10.3389/fchem.2022.996264. eCollection 2022. Front Chem. 2022. PMID: 36267658 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical